Press Releases Keyword Search Year None20202019201820172016 Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor September 3, 2020 Relay Therapeutics Reports Second Quarter 2020 Financial Results August 27, 2020 Relay Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares July 20, 2020 Relay Therapeutics Announces Pricing of Initial Public Offering July 15, 2020 Relay Therapeutics Announces Formation of Oncology Advisory Board March 4, 2020 Relay Therapeutics Appoints Dr. James Nichols to Lead Expansion into Genetic Diseases February 4, 2020 Relay Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference January 6, 2020
